v3.26.1
NATURE OF BUSINESS & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 12 Months Ended
Dec. 31, 2025
Accounting Policies [Abstract]  
Schedule of Deferred Revenue Activity The following table represents the deferred revenue activity for the years ended December 31, 2025, and 2024:
In ThousandsDeferred Revenue
Balance as of December 31, 2023$1,210 
Unearned revenue from cash received during the period932 
Revenue recognized that was included in the balance at the beginning of the period(1,210)
Balance as of December 31, 2024932 
Unearned revenue from cash received during the period536 
Revenue recognized that was included in the balance at the beginning of the period(932)
Balance as of December 31, 2025$536 
Schedule of Computation of Basic and Diluted Net Loss Per Share of Class A Common Stock


The following table shows the computation of basic and diluted net loss per share of Class A Common Stock for the years ended December 31, 2025, and 2024:

Years Ended December 31,
In Thousands, Except Share and Per Share Amounts20252024
Numerator:
Net loss attributable to Cibus, Inc. stockholders$(127,085)$(251,388)
Denominator:
Weighted average shares of Class A common stock outstanding43,832,58123,172,256
Effect of pre-funded warrants1,924,79550,000
Weighted average shares of Class A common stock outstanding – basic and diluted45,757,37623,222,256
Basic and diluted net loss per share of Class A common stock$(2.78)$(10.83)
Schedule of Antidilutive Securities Excluded from Computation of Loss Per Share The following potential dilutive securities, presented on an as converted basis, were excluded from the calculation of net loss per share of Class A Common Stock due to their antidilutive effect:
As of December 31,
20252024
Stock options outstanding1,358,797572,264
Unvested restricted stock units1,359,207779,861
Unvested restricted stock awards85,185274,058
Common warrants10,496,5231,456,523
Total13,299,7123,082,706
Schedule of Segment Financial Information Used by CODM to Assess Segment Performance and Make Decisions
Segment financial information, including significant segment expenses, which are regularly provided to the CODM and included in net loss was as follows:

Years Ended December 31,
In Thousands20252024
Revenue$3,639 $4,262 
Less:
Personnel expenses26,36429,024
Professional fees10,29511,363
Stock-based compensation8,18810,750
Goodwill impairment20,950181,432
Long-lived assets impairment9,115—
Other segment expenses (1)
26,25630,089
Total operating expenses101,168262,658
Loss from operations(97,529)(258,396)
Royalty liability interest expense - related parties(35,481)(34,190)
Other interest income, net438631
Non-operating income, net4009,271
Income tax expense(29)(29)
Total segment loss$(132,201)$(282,713)

_______________________________________
(1) Other segment expenses are primarily comprised of insurance, loss on asset disposal, amortization and depreciation, rent and utilities, lab supplies, product development, and selling and marketing expenses.
Schedules of Concentration of Risk, by Risk Factor The following table illustrates customer concentration as a percentage of total revenue:
Years Ended December 31,
Concentration of revenue greater than 10% of total company revenues20252024
Customer A76.8%77.3%
Customer B13.9%11.9%


The following table illustrates customer concentration as a percentage of total accounts receivable:

Years Ended December 31,
Concentration of accounts receivable greater than 10% of the total accounts receivable balance20252024
Customer A79.6%87.0%
Customer B20.4%13.0%